Personal Use of Hormone Therapy by Menopausal Female Physicians and Physician's Relatives in Taiwan

• Main Authors: Chien-Yu Yin, 錢宥尹
• Other Authors: Cheng-Hua Lee
• Format: Others
• Language: zh-TW
• Published: 2010
• Online Access: http://ndltd.ncl.edu.tw/handle/24273686825322193749

碩士 === 國立陽明大學 === 醫務管理研究所 === 98 === Backgrounds World Health Organization estimated that there would be up to 1.2 billion of women with menopause by year 2030. As menopause is the process of life that every woman must go through, menopausal symptoms in women often cause discomfort; therefore most women are in need of hormone therapy to relieve such symptoms. In 2002, the USA WHI reported women who had long-term treatment for hormone therapy may have high risk in breast cancer and cardiovascular disease, causing health professionals concern about the safety and adequacy of hormone therapy. As professionally trained paramedics understand the pros and cons of hormone therapy better than women in general, yielding asymmetry of medical information in result. In 2006, an Italian research reveals that after the release of the WHI, utilization of hormone therapy among female physicians and their relatives is still significantly higher than women in general. Hence, in this research, we intend to compare the utilization of hormone therapy among Taiwan's female physicians, female relatives of physicians and women in general. Object This study is to compare the treatment of hormone therapy among Taiwan's female physicians, female relatives of physicians and women in general. Methods Retrospective analyses were conducted by using National Health Insurance data for female physicians, physicians’ relatives and non-health personal, who were 40 to 69 of age in 2006. Logistic Regression model was used. Results Approximately 8.66% of postmenopausal Taiwanese women involve in hormone therapy (HT) during 2006, while 7.05% were female physicians. After controlling the confounding variables, female physicians were significantly less likely to receive hormone therapy than other women (OR:0.753;CI:0.652-0.87). Conclusions In Taiwan, female physicians and their relatives who receive HT are significantly lower than postmenopausal population of other countries.